<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7194560\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="and found a suitable save drugs for repurposing against the" exact="viral" post="Mpro. Ribavirin, telbivudine, vitamin B12 and nicotinamide can be"/>
  <result pre="safe drugs for potential use in COVID-treatment. Abbreviations COVID-19, Coronavirus" exact="disease" post="2019 2019-nCoV, 2019 New Coronavirus MERS CoV, Middle East"/>
  <result pre="disease 2019 2019-nCoV, 2019 New Coronavirus MERS CoV, Middle East" exact="Respiratory" post="Syndrome Coronavirus ORF, open reading frames S, spike protein"/>
  <result pre="2019 2019-nCoV, 2019 New Coronavirus MERS CoV, Middle East Respiratory" exact="Syndrome" post="Coronavirus ORF, open reading frames S, spike protein E,"/>
  <result pre="envelope M, membrane protein N, nucleocapsid 3CLpro, 3-C-like protease SARS," exact="Severe" post="Acute Respiratory Syndrome CoV Keywords COVID-19, 2019-nCoV 2019-Novel Coronavirus"/>
  <result pre="M, membrane protein N, nucleocapsid 3CLpro, 3-C-like protease SARS, Severe" exact="Acute" post="Respiratory Syndrome CoV Keywords COVID-19, 2019-nCoV 2019-Novel Coronavirus Wuhan"/>
  <result pre="membrane protein N, nucleocapsid 3CLpro, 3-C-like protease SARS, Severe Acute" exact="Respiratory" post="Syndrome CoV Keywords COVID-19, 2019-nCoV 2019-Novel Coronavirus Wuhan Coronavirus"/>
  <result pre="protein N, nucleocapsid 3CLpro, 3-C-like protease SARS, Severe Acute Respiratory" exact="Syndrome" post="CoV Keywords COVID-19, 2019-nCoV 2019-Novel Coronavirus Wuhan Coronavirus Main"/>
  <result pre="Molecular modeling 1 Introduction Recently, a severe and highly contagious" exact="viral" post="disease was evolved in Wuhan, China [1]. The causative"/>
  <result pre="modeling 1 Introduction Recently, a severe and highly contagious viral" exact="disease" post="was evolved in Wuhan, China [1]. The causative agent"/>
  <result pre="detected to be a new coronavirus and termed as Coronavirus" exact="disease" post="2019 (COVID-19). Coronavirus has been associated with several infectious"/>
  <result pre="Coronavirus disease 2019 (COVID-19). Coronavirus has been associated with several" exact="infectious" post="epidemics with major health hazard concerns. In 2000â€&quot;2004, the"/>
  <result pre="infectious epidemics with major health hazard concerns. In 2000â€&quot;2004, the" exact="Severe" post="Acute Respiratory Syndrome CoV (SARS CoV) was evolved [2]."/>
  <result pre="epidemics with major health hazard concerns. In 2000â€&quot;2004, the Severe" exact="Acute" post="Respiratory Syndrome CoV (SARS CoV) was evolved [2]. The"/>
  <result pre="with major health hazard concerns. In 2000â€&quot;2004, the Severe Acute" exact="Respiratory" post="Syndrome CoV (SARS CoV) was evolved [2]. The source"/>
  <result pre="major health hazard concerns. In 2000â€&quot;2004, the Severe Acute Respiratory" exact="Syndrome" post="CoV (SARS CoV) was evolved [2]. The source of"/>
  <result pre="CoV (SARS CoV) was evolved [2]. The source of the" exact="infection" post="was recorded from animal origins, including a bat as"/>
  <result pre="was recorded from animal origins, including a bat as an" exact="intermediate" post="host [3]. About a decade later, the Middle East"/>
  <result pre="intermediate host [3]. About a decade later, the Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS CoV) was diagnosed in Saudi Arabia"/>
  <result pre="host [3]. About a decade later, the Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS CoV) was diagnosed in Saudi Arabia [4]."/>
  <result pre="against emerging and fatal diseases including SARS CoV proteases [19,20]," exact="Hepatitis" post="C virus RNA-dependent RNA polymerase [21], dengue virus [22]"/>
  <result pre="comparison matrix of COVID-19, SARS and MERS CoVs Mpro. The" exact="upper" post="diagonal panel shows the number of amino acids differences."/>
  <result pre="diagonal panel shows the number of amino acids differences. The" exact="lower" post="diagonal panel shows the identity%. Table 1 COVID-19 SARS"/>
  <result pre="0.37 4.36 Antiviral Telbivudine C10H14N2O5 242 2.00 3.19 0.44 6.12" exact="Hepatitis" post="B virus Vitamin B12 C63H88CoN14O14P 1355 1.99 0.60 0.49"/>
  <result pre="0.12 3.20 Anticancer Methazolamide C5H8N4O3S2 236 1.78 3.45 0.00 5.76" exact="Glaucoma" post="Tioxolone C7H4O3S 168 1.78 4.38 0.92 3.20 Anti-acne Propylthiouracil"/>
  <result pre="agent Cysteamine HCl C2H8ClNS 114 1.77 12.01 0.00 2.00 Nephropathic" exact="cystinosis" post="methoxamine hydrochloride C11H18ClNO3 248 1.77 3.20 0.10 5.09 Alpha-adrenergic"/>
  <result pre="spectrum antiviral agent acting by induction of mutations in the" exact="viral" post="genome, especially in RNA viruses [24]. Ribavirin is officially"/>
  <result pre="in RNA viruses [24]. Ribavirin is officially approved for treating" exact="respiratory" post="syncytial virus (RSV) infection and, in combination with interferon"/>
  <result pre="Ribavirin is officially approved for treating respiratory syncytial virus (RSV)" exact="infection" post="and, in combination with interferon Î±2b for hepatitis C"/>
  <result pre="virus (RSV) infection and, in combination with interferon Î±2b for" exact="hepatitis C" post="virus [25]. In addition, it was used for treating"/>
  <result pre="[25]. In addition, it was used for treating SARS CoV" exact="infections" post="[25]. Given the high similarity of SARS and COVID-19"/>
  <result pre="a value in treating COVID-19. Telbivudine is approved for treating" exact="hepatitis" post="B virus [26]. The drug is nucleoside analogue and"/>
  <result pre="[26]. The drug is nucleoside analogue and best fits the" exact="viral" post="polymerase. The high rank of telbivudine in this study"/>
  <result pre="China Life Sci.20201431564034 2PeirisJ.LaiS.PoonL.GuanY.YamL.LimW.Coronavirus as a possible cause of severe" exact="acute" post="respiratory syndromeLancet36120031319132512711465 3LiW.WongS.-K.LiF.KuhnJ.H.HuangI.-C.ChoeH.Animal origins of the severe acute respiratory"/>
  <result pre="Life Sci.20201431564034 2PeirisJ.LaiS.PoonL.GuanY.YamL.LimW.Coronavirus as a possible cause of severe acute" exact="respiratory" post="syndromeLancet36120031319132512711465 3LiW.WongS.-K.LiF.KuhnJ.H.HuangI.-C.ChoeH.Animal origins of the severe acute respiratory syndrome"/>
  <result pre="of severe acute respiratory syndromeLancet36120031319132512711465 3LiW.WongS.-K.LiF.KuhnJ.H.HuangI.-C.ChoeH.Animal origins of the severe" exact="acute" post="respiratory syndrome coronavirus: insight from ACE2-S-protein interactionsJ. Virol.8020064211421916611880 4ZakiA.M.van"/>
  <result pre="severe acute respiratory syndromeLancet36120031319132512711465 3LiW.WongS.-K.LiF.KuhnJ.H.HuangI.-C.ChoeH.Animal origins of the severe acute" exact="respiratory" post="syndrome coronavirus: insight from ACE2-S-protein interactionsJ. Virol.8020064211421916611880 4ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation"/>
  <result pre="acute respiratory syndromeLancet36120031319132512711465 3LiW.WongS.-K.LiF.KuhnJ.H.HuangI.-C.ChoeH.Animal origins of the severe acute respiratory" exact="syndrome" post="coronavirus: insight from ACE2-S-protein interactionsJ. Virol.8020064211421916611880 4ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of"/>
  <result pre="4ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN. Engl. J. Med.36720121814182023075143 5DesenclosJ.-C.Van der WerfS.BonmarinI.Levy-BruhlD.YazdanpanahY.HoenB.Introduction"/>
  <result pre="plant terpenoids and lignoids possess potent antiviral activities against severe" exact="acute" post="respiratory syndrome coronavirusJ. Med. Chem.5020074087409517663539 14AltaherY.KandeelM.Molecular analysis of some"/>
  <result pre="terpenoids and lignoids possess potent antiviral activities against severe acute" exact="respiratory" post="syndrome coronavirusJ. Med. Chem.5020074087409517663539 14AltaherY.KandeelM.Molecular analysis of some camel"/>
  <result pre="and lignoids possess potent antiviral activities against severe acute respiratory" exact="syndrome" post="coronavirusJ. Med. Chem.5020074087409517663539 14AltaherY.KandeelM.Molecular analysis of some camel cytochrome"/>
  <result pre="Chem.5020074087409517663539 14AltaherY.KandeelM.Molecular analysis of some camel cytochrome P450 enzymes reveals" exact="lower" post="evolution and drug-binding propertiesJ. Biomol. Struct. Dyn.34201611512425640974 15AltaherY.NakanishiM.KandeelM.Annotation of"/>
  <result pre="Inf. Comput. Sci.4420041111112215154780 21ElHefnawiM.ElGamacyM.FaresM.Multiple virtual screening approaches for finding new" exact="Hepatitis" post="c virus RNA-dependent RNA polymerase inhibitors: structure-based screens and"/>
 </snippets>
</snippetsTree>
